Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
01/28/00 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.13
EX-21
EX-23.1
EX-27
EX-99.1
HTML PDF 60
03/31/99 10-K/A Annual report pursuant to section 13 and 15(d) HTML PDF 13
01/29/99 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-21
EX-23.1
EX-27
HTML PDF 42
01/29/98 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-21
EX-23.1
EX-27
HTML PDF 40
01/29/97 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-23.1
EX-27
EX-99.1
HTML PDF 35
01/29/96 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-10.31
EX-23.1
EX-27
HTML PDF 44
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Jun 21, 2022

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology

Read More...
May 5, 2022

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference

Read More...
Apr 28, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read More...
Copyrights © 2022 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap